W. T. Robertson

发表

Peripheral neuropathy in a cohort of human immunodeficiency virus-infected patients. Incidence and relationship to other nervous system dysfunction.

C. R. Snyder, C. Hall, K. Robertson, 1991, Archives of neurology.

Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection

T. Parsons, C. Hall, K. Robertson, 2006, AIDS.

Neuropsychologic functioning of human immunodeficiency virus-infected children with hemophilia.

S. Hooper, M. Burchinal, M. Tennison, 1993, The Journal of pediatrics.

The Minnesota Multiphasic Personality Inventory—2 across the Human Immunodeficiency Virus Spectrum

C. Hall, K. Robertson, W. T. Robertson, 2002, Assessment.

Cerebrospinal fluid analysis in human immunodeficiency virus infection.

C. R. Snyder, C. Hall, K. Robertson, 1992, Annals of clinical and laboratory science.

Highly Active Antiretroviral Therapy Improves Neurocognitive Functioning

C. Hall, K. Robertson, S. Fiscus, 2004, Journal of acquired immune deficiency syndromes.

No Gender Differences in the Progression of Nervous System Disease in HIV Infection

C. Hall, K. Robertson, S. Fiscus, 2004, Journal of acquired immune deficiency syndromes.

Timed Gait Test: Normative Data for the Assessment of the AIDS Dementia Complex

Thomas D. Parsons, John J. Sidtis, Richard W. Price, 2006, Journal of clinical and experimental neuropsychology.

Psychoimmunology and aids: Psychological distress and herpes simplex virus in human immunodeficiency virus infected individuals

C. Hall, K. Robertson, J. Fryer, 1993 .

The importance of confounding factors in the evaluation of neuropsychological changes in patients infected with human immunodeficiency virus.

C. Hall, K. Robertson, J. Fryer, 1990, Journal of Acquired Immune Deficiency Syndromes.

Assessing health-related quality of life in NeuroAIDS: Some psychometric properties of the Neurological Quality of Life Questionnaire (NeuroQOL)

T. Parsons, C. Hall, K. Robertson, 2007, Journal of Clinical Neuroscience.

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team.

M. Lederman, C. Yiannoutsos, K. Marder, 1999, AIDS.

CSF, plasma viral load and HIV associated dementia.

C. Hall, K. Robertson, S. Fiscus, 1998, Journal of neurovirology.